Search Legislation

The Medicines (Advisory Bodies) Regulations 2005

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Changes over time for: Paragraph 14

 Help about opening options

Alternative versions:

Status:

This version of this contains provisions that are prospective. Help about Status

Changes to legislation:

There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Medicines (Advisory Bodies) Regulations 2005. Any changes that have already been made by the team appear in the content and are referenced with annotations. Help about Changes to Legislation

Prospective

This section has no associated Explanatory Memorandum

14.  In section 132 of the Act (general interpretation provisions), in subsection (1)—U.K.

(a)before the definition of “analysis”, insert the following definition—

“Advisory Body” has the meaning given to it by paragraph 1 of Schedule 1A to this Act;,

(b)in the definition of “the Commission”, for “Medicines Commission” substitute “Commission for Human Medicines”;

(c)after the definition of “enforcement authority”, insert the following definition—

“Expert Advisory Group” means an Expert Advisory Group established under paragraph 3 or 4 of Schedule 1A to this Act;;

(d)after the definition of “herd”, insert the following definition—

“the Homoeopathic Regulations” means the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994(1);

(e)after the definition of “manufacture”, insert the following definition—

“the Marketing Authorisation Regulations” means the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994;;

(f)in the definition of “the time allowed”, for “section 21(8)” substitute “section 21(12)”.

Commencement Information

I1Sch. 1 para. 14 in force at 30.10.2005, see reg. 1(1)

Back to top

Options/Help